Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

A judge in California has ruled that a law banning so-called pay-to-delay deals between pharma companies cannot be enforced ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

Glenmark launches Latanoprost Ophthalmic Solution, targeting $113.5 million market, showcasing commitment to quality eye care ...

According to IQVIA, sales data for the 12-month period ending December 2024, the Xalatan Ophthalmic Solution achieved annual ...

Glenmark Pharmaceuticals launches a generic ophthalmic solution for glaucoma in the US market, adding to its growing ...

Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® ...

DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the ...